Harvard Bioscience Inc HBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.95
- Day Range
- $5.95–6.32
- 52-Week Range
- $3.76–9.40
- Bid/Ask
- $5.53 / $7.00
- Shares Outstanding
- 4.51M
- Market Cap
- $28.10M
- Volume/Avg
- 14,399 / 26,441
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.32
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 339
Valuation
|
Metric
|
HBIO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.80 |
Price/Sales | 0.32 |
Price/Cash Flow | 220.27 |
Price/Earnings
HBIO
Financial Strength
|
Metric
|
HBIO
|
|---|---|
Quick Ratio | 0.91 |
Current Ratio | 1.99 |
Interest Coverage | −0.69 |
Quick Ratio
HBIO
Profitability
|
Metric
|
HBIO
|
|---|---|
Return on Assets (Normalized) | −9.60% |
Return on Equity (Normalized) | −55.53% |
Return on Invested Capital (Normalized) | −3.17% |
Return on Assets
HBIO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|<$hYM!! | LOCK|J?g | $122B | |||
| Becton Dickinson & Co
BDX
| LOCK|&c% | LOCK|yzh%> | $44B | |||
| Alcon Inc
ALC
| LOCK|S#zV&CH | LOCK|>s@< | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|Q&!Kx$# | LOCK|Qcg& | $34B | |||
| ResMed Inc
RMD
| LOCK|^HxTCFx> | LOCK|#WjbV | $29B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|ywt<rBnq | LOCK|G$j | $25B | |||
| Solventum Corp
SOLV
| LOCK|nW>hCx | LOCK|#<? | $14B | |||
| The Cooper Companies Inc
COO
| LOCK|%T^L?l | LOCK|PW>Cz | $14B | |||
| Align Technology Inc
ALGN
| LOCK|yMMvF> | LOCK|vgxvD | $13B | |||
| Baxter International Inc
BAX
| LOCK|!z | LOCK|m!fs | $12B |
United States